My Quote Request
6505-01-365-2068
20 Products
NDC00023-5487-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505013652068
NSN
6505-01-365-2068
NDC00023-5487-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505013652068
NSN
6505-01-365-2068
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V CARBOXYMETHYLCELLULOSE SODIUM ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 0.01ML AMPUL 30S
PRIMARY CONTAINER CONTENT QUANTITY: 0.010 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 30
Related Searches:
A92H282
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505013652072
NSN
6505-01-365-2072
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM TABLETS USP 0.5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00378-0321-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505013652072
NSN
6505-01-365-2072
NDC00378-0321-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505013652072
NSN
6505-01-365-2072
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM TABLETS USP 0.5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC52544-0244-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505013652072
NSN
6505-01-365-2072
NDC52544-0244-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505013652072
NSN
6505-01-365-2072
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM TABLETS USP 0.5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
FREAMINE III 10%
AMINO ACID INJECTION
NSN, MFG P/N
6505013652361
NSN
6505-01-365-2361
FREAMINE III 10%
AMINO ACID INJECTION
NSN, MFG P/N
6505013652361
NSN
6505-01-365-2361
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: WITHOUT ELECTROLYTES
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00264-1901-00
AMINO ACID INJECTION
NSN, MFG P/N
6505013652361
NSN
6505-01-365-2361
NDC00264-1901-00
AMINO ACID INJECTION
NSN, MFG P/N
6505013652361
NSN
6505-01-365-2361
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: WITHOUT ELECTROLYTES
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
S9010
AMINO ACID INJECTION
NSN, MFG P/N
6505013652361
NSN
6505-01-365-2361
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: WITHOUT ELECTROLYTES
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
02-0003
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
02-0003
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS NORETHINDRONE ACTIVE INGREDIENT AND 0.035 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORETHINDRONE 1MG AND ETHINYL ESTRADOIL 35MCG TABLETS (NORINYL 1/35)
PRIMARY CONTAINER CONTENT QUANTITY: 28.000 TABLETS
PRIMARY CONTAINER TYPE: DISPENSER-DIAL
SPECIAL FEATURES: 168 TABLETS; 28 DAY REGIMEN; 144 CYCLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00062-1761-15
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
NDC00062-1761-15
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
MFG
ORTHO-MCNEIL PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS NORETHINDRONE ACTIVE INGREDIENT AND 0.035 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORETHINDRONE 1MG AND ETHINYL ESTRADOIL 35MCG TABLETS (NORINYL 1/35)
PRIMARY CONTAINER CONTENT QUANTITY: 28.000 TABLETS
PRIMARY CONTAINER TYPE: DISPENSER-DIAL
SPECIAL FEATURES: 168 TABLETS; 28 DAY REGIMEN; 144 CYCLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
ORTHO NOVUM 1/35
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
ORTHO NOVUM 1/35
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505013652363
NSN
6505-01-365-2363
MFG
ORTHO-MCNEIL PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS NORETHINDRONE ACTIVE INGREDIENT AND 0.035 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORETHINDRONE 1MG AND ETHINYL ESTRADOIL 35MCG TABLETS (NORINYL 1/35)
PRIMARY CONTAINER CONTENT QUANTITY: 28.000 TABLETS
PRIMARY CONTAINER TYPE: DISPENSER-DIAL
SPECIAL FEATURES: 168 TABLETS; 28 DAY REGIMEN; 144 CYCLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-9791-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013652650
NSN
6505-01-365-2650
NDC00074-9791-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013652650
NSN
6505-01-365-2650
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.2% W/V EGG PHOSPHATIDES ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITHOUTADMINSTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
5B5193
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013652651
NSN
6505-01-365-2651
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: WITH 2 PORTS (MEDICAL AND OUTLET PORT); COMPOSITION PER 100 ML.: DEXTROSE 1.5 GRAMS; SODIUM CHLORIDE 538 MG.; SODIUM LACTATE 448 MG.; CALCIUM CHLORIDE 25.7 MG.; MAGNESIUM CHLORIDE 5.08 MG.
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
DIANEAL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013652651
NSN
6505-01-365-2651
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: WITH 2 PORTS (MEDICAL AND OUTLET PORT); COMPOSITION PER 100 ML.: DEXTROSE 1.5 GRAMS; SODIUM CHLORIDE 538 MG.; SODIUM LACTATE 448 MG.; CALCIUM CHLORIDE 25.7 MG.; MAGNESIUM CHLORIDE 5.08 MG.
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
NDC00941-0411-25
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013652651
NSN
6505-01-365-2651
NDC00941-0411-25
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013652651
NSN
6505-01-365-2651
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: WITH 2 PORTS (MEDICAL AND OUTLET PORT); COMPOSITION PER 100 ML.: DEXTROSE 1.5 GRAMS; SODIUM CHLORIDE 538 MG.; SODIUM LACTATE 448 MG.; CALCIUM CHLORIDE 25.7 MG.; MAGNESIUM CHLORIDE 5.08 MG.
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
PD-2
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013652651
NSN
6505-01-365-2651
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: WITH 2 PORTS (MEDICAL AND OUTLET PORT); COMPOSITION PER 100 ML.: DEXTROSE 1.5 GRAMS; SODIUM CHLORIDE 538 MG.; SODIUM LACTATE 448 MG.; CALCIUM CHLORIDE 25.7 MG.; MAGNESIUM CHLORIDE 5.08 MG.
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
133637
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013657177
NSN
6505-01-365-7177
133637
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013657177
NSN
6505-01-365-7177
MFG
MAJOR CROWN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00904-0359-70
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013657177
NSN
6505-01-365-7177
NDC00904-0359-70
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013657177
NSN
6505-01-365-7177
MFG
MAJOR CROWN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DILACOR-XR 120
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013658942
NSN
6505-01-365-8942
DILACOR-XR 120
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013658942
NSN
6505-01-365-8942
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEN EXTENDED-RELEASE CAPSULES USP 120MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RHONE-POULENC-RORER
Related Searches:
NDC00075-0250-00
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013658942
NSN
6505-01-365-8942
NDC00075-0250-00
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013658942
NSN
6505-01-365-8942
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEN EXTENDED-RELEASE CAPSULES USP 120MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RHONE-POULENC-RORER
Related Searches:
CORGARD
NADOLOL TABLETS,USP
NSN, MFG P/N
6505013660939
NSN
6505-01-366-0939
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO